These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10733554)

  • 1. Fas-mediated cholangiopathy in the murine model of graft versus host disease.
    Ueno Y; Ishii M; Yahagi K; Mano Y; Kisara N; Nakamura N; Shimosegawa T; Toyota T; Nagata S
    Hepatology; 2000 Apr; 31(4):966-74. PubMed ID: 10733554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease.
    Bobé P; Bonardelle D; Reynès M; Godeau F; Mahiou J; Joulin V; Kiger N
    J Immunol; 1997 Nov; 159(9):4197-204. PubMed ID: 9379013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.
    Ilan Y; Margalit M; Ohana M; Gotsman I; Rabbani E; Engelhardt D; Nagler A
    Hum Immunol; 2005 Mar; 66(3):231-40. PubMed ID: 15784461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of novel anti-human Fas antibody HFE7a on graft-versus-host disease model.
    Kuwahara H; Tani Y; Ogawa Y; Takaichi Y; Shiraishi A; Ohtsuki M
    Clin Immunol; 2001 Jun; 99(3):340-6. PubMed ID: 11358429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immortalized intrahepatic mouse biliary epithelial cells: immunologic characterization and immunogenicity.
    Hreha G; Jefferson DM; Yu CH; Grubman SA; Alsabeh R; Geller SA; Vierling JM
    Hepatology; 1999 Aug; 30(2):358-71. PubMed ID: 10421641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic homing of mononuclear inflammatory cells isolated during murine chronic graft-vs-host disease.
    Howell CD; Yoder T; Claman HN; Vierling JM
    J Immunol; 1989 Jul; 143(2):476-83. PubMed ID: 2472440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of human CD40-Ig fusion protein in a murine model of acute graft-versus-host disease.
    Liu H; Mao N; Hou C; Li X; Shen B; Tang PH
    Chin Med J (Engl); 2001 Jul; 114(7):685-9. PubMed ID: 11780327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of autoimmune disease in Fas-deficient mice by treatment with a cytotoxic benzodiazepine.
    Bednarski JJ; Warner RE; Rao T; Leonetti F; Yung R; Richardson BC; Johnson KJ; Ellman JA; Opipari AW; Glick GD
    Arthritis Rheum; 2003 Mar; 48(3):757-66. PubMed ID: 12632430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease.
    Georgantas RW; Bohana-Kashtan O; Civin CI
    Transplantation; 2006 Aug; 82(4):471-8. PubMed ID: 16926590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice.
    Nagler A; Pines M; Abadi U; Pappo O; Zeira M; Rabbani E; Engelhardt D; Ohana M; Chowdhury NR; Chowdhury JR; Ilan Y
    Hepatology; 2000 Mar; 31(3):641-8. PubMed ID: 10706554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD.
    El-Hayek JM; Rogers TE; Brown GR
    J Leukoc Biol; 2005 Oct; 78(4):1001-7. PubMed ID: 16081594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity.
    Ilan Y; Ohana M; Pappo O; Margalit M; Lalazar G; Engelhardt D; Rabbani E; Nagler A
    Transplantation; 2007 Feb; 83(4):458-67. PubMed ID: 17318079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Fas/Fas ligand-mediated apoptosis in murine contact hypersensitivity.
    Xu B; Bulfone-Paus S; Aoyama K; Yu S; Huang P; Morimoto K; Matsushita T; Takeuchi T
    Int Immunopharmacol; 2003 Jul; 3(7):927-38. PubMed ID: 12810350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory arthropathy in MRL hematopoietic chimeras undergoing Fas mediated graft-versus-host syndrome.
    Bonardelle D; Bobé P; Reynès M; Amouroux J; Tricottet V; Godeau F; Kiger N
    J Rheumatol; 2001 May; 28(5):956-61. PubMed ID: 11361222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligoclonal expansion of T cell receptor V beta 2 and 3 cells in the livers of mice with graft-versus-host disease.
    Chen W; Howell CD
    Hepatology; 2002 Jan; 35(1):23-9. PubMed ID: 11786956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD3 induces bi-phasic apoptosis in murine intestinal epithelial cells: possible involvement of the Fas/Fas ligand system in different T cell compartments.
    Miura N; Yamamoto M; Fukutake M; Ohtake N; Iizuka S; Ishige A; Sasaki H; Fukuda K; Yamamoto T; Hayakawa S
    Int Immunol; 2005 May; 17(5):513-22. PubMed ID: 15778290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury.
    Yu WR; Liu T; Fehlings TK; Fehlings MG
    Eur J Neurosci; 2009 Jan; 29(1):114-31. PubMed ID: 19120440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotide inhibition of Bcl-xL and Bid expression in liver regulates responses in a mouse model of Fas-induced fulminant hepatitis.
    Zhang H; Taylor J; Luther D; Johnston J; Murray S; Wyatt JR; Watt AT; Koo S; York-DeFalco C; Stecker K; Dean NM
    J Pharmacol Exp Ther; 2003 Oct; 307(1):24-33. PubMed ID: 12893848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation model.
    Fujioka T; Taniguchi Y; Masuda T; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Hosen N; Murakami M; Oji Y; Oka Y; Sugiyama H; Kawase I; Ogawa H
    Transpl Immunol; 2003; 11(2):187-95. PubMed ID: 12799203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.